D. Kamel

发表

Prolonged progression free interval in a patient with locally recurrent small cell lung cancer presenting with cerebellar paraneoplastic syndrome

A. Bezjak, A. Boag, M. Mates, 2015 .

PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials.

C. Gray, J. Walia, D. Kamel, 2018, Current drug targets.

Proteomic classification of breast cancer.

Gordon B Mills, Adel Tabchy, G. Mills, 2012, Current drug targets.

Cathepsin H expression distinguishes oncocytomas from renal cell carcinomas.

Y. Collan, M. Nurmi, D. Kamel, 2000, Anticancer research.

Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review

B. Hutton, M. Clemons, D. Fergusson, 2018, Breast cancer research and treatment.

Increased Incidence of Ventricular Arrhythmias in Patients With Advanced Cancer and Implantable Cardioverter-Defibrillators.

A. Baranchuk, D. Redfearn, J. Biagi, 2017, JACC. Clinical electrophysiology.

Staging Investigations in Asymptomatic Early Breast Cancer Patients at the Cancer Centre of Southeastern Ontario

W. Hopman, M. Mates, D. Kamel, 2021, Current oncology.

Increased Incidence of Ventricular Arrhythmias in Patients With Advanced Cancer and Implantable Cardioverter-Defibrillators.

A. Baranchuk, D. Redfearn, J. Biagi, 2017, JACC. Clinical electrophysiology.

PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials.

C. Gray, J. Walia, D. Kamel, 2018, Current drug targets.